- Stories /
- Healthcare /
- SaniSure /
Created one of the largest independent single-use solutions platforms in the bioprocessing industry through innovation and buy-and-build
2019 – Current
Good to great
4x
sales in 2024 compared to 2019Launching innovative, proprietary solutions serving high-value customer needs in critical process steps
6
acquisitions completed since investmentCompleted six acquisitions to form the global platform, accelerating each acquired business’s international growth
>1,000
pharmaceutical, CDMO and biotech customersIncreasing portfolio exposure to the high-growth biologics and cell and gene therapy markets
Investing to support commercial and operational excellence initiatives to better serve our customers